在炎症和癌症中的NF-κB
Hongmei Mao1, Xiaocui Zhao1, Shao-Cong Sun2,3
1Institute for Immunology, Chinese Institutes for Medical Research, Beijing, China.
Cellular & molecular immunology
|June 25, 2025
概括
核因子-卡帕B (NF-κB) 在炎症和癌症中起着关键作用. 针对这种途径提供了潜在的治疗策略,用于炎症性疾病和癌症,尽管存在挑战.
科学领域:
- 分子生物学分子生物学
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
背景情况:
- 核因子-kappa B (NF-κB) 是一个转录因子家族,调节免疫反应,炎症,细胞生长和存活.
- 失调的NF-κB激活与炎症性疾病,自身免疫性疾病和癌症发展有关.
- 在瘤发生过程中NF-κB的作用包括促进瘤细胞增殖,生存,新陈代谢,转移,血管生成和治疗耐药性.
研究的目的:
- 审查最近关于NF-κB在病理过程中的作用的发现.
- 讨论NF-κB参与疾病的潜在机制.
- 探索针对NF-κB途径的治疗策略,并分析潜在的挑战.
主要方法:
- 最近科学发现的文献综述.
- 分子机制的分析.
- 探索治疗策略和挑战.
主要成果:
- NF-κB失调有助于炎症和自身免疫性疾病.
- NF-κB与癌症的发展和进展有关.
- 向NF-κB对炎症性疾病和癌症具有治疗潜力.
结论:
- NF-κB是炎症和癌症的关键调解者.
- 准NF-κB通路是一个有前途的治疗途径.
- 需要进一步的研究来克服NF-κB向疗法的挑战.
相关概念视频
NF-κB-dependent Signaling Pathway
7.9K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
7.9K
Co-activators and Co-repressors
7.6K
Gene transcription is regulated by the synergistic action of several proteins that form a complex at a gene regulatory site. This is observed in eukaryotes, where the regulation of gene expression is a complex process. Regulatory proteins in eukaryotes can broadly be classified into two types – regulators that bind directly to specific DNA sequences and co-regulators that associate with regulatory proteins but cannot directly bind to the DNA. These co-regulators are further divided into...
7.6K
The Intrinsic Apoptotic Pathway
6.9K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.9K
Inflammatory Response
8.5K
An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
8.5K
The JAK-STAT Signaling Pathway
9.3K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
9.3K
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
240
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
240


